FDA Inspection 663034 — Department of Defense - Naval Hospital Camp Pendleton

Department of Defense - Naval Hospital Camp Pendleton — FEI 2076574

The FDA completed an inspection of Department of Defense - Naval Hospital Camp Pendleton on May 19, 2010 in Camp Pendleton, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 19, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Camp Pendleton, CA (United States)